[144] Medpace Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) Form 144 notice shows an intended sale of 10,000 common shares through Fidelity Brokerage Services on 09/03/2025 with an aggregate market value of $4,800,019.30. The shares were acquired by the seller via a stock option exercise on 08/05/2024 and paid in cash. The filing reports 28,093,026 shares outstanding. The same person sold 7,500 shares on 07/28/2025 for gross proceeds of $3,376,083.14. The filer attests there is no undisclosed material adverse information and includes the required sale and acquisition details.

Positive

• Transparent sourcing: Shares were acquired by a stock option exercise on 08/05/2024 and paid in cash, clearly disclosed
• Complete sale details: Broker, number of shares, aggregate market value, and approximate sale date are provided
• Attestation included: Seller represents no undisclosed material adverse information, satisfying a key Rule 144 requirement

Negative

• Insider selling: Planned sale of 10,000 shares and a recent sale of 7,500 shares may be viewed negatively by some investors
• Lack of trading-plan detail: Form does not indicate adoption date of any 10b5-1 trading plan or instruction in the provided fields

Insights

Securities Analyst

TL;DR Insider plans to sell 10,000 shares acquired by option exercise; prior sale of 7,500 shares reported recently.

This Form 144 discloses a routine insider sale executed through a broker with clear sourcing: the 10,000 shares were acquired by exercising options and paid in cash on 08/05/2024. The planned sale value of about $4.8 million is explicitly stated. Compared with the reported 28,093,026 shares outstanding, the 10,000-share sale represents a very small fraction of the float, indicating limited direct dilution or market impact from this single notice. Recent sale activity of 7,500 shares on 07/28/2025 for roughly $3.38 million shows continued disposition of shares by the same person within the reporting window. Overall this appears procedural and compliant with Rule 144 disclosure norms.

Corporate Governance Expert

TL;DR Filing documents insider exercise and subsequent sales; disclosure language affirms no undisclosed material information.

The notice includes the required attestation that the seller is not aware of undisclosed material adverse information. The acquisition method (stock option exercise) and cash payment are clearly documented, which supports transparent governance practices around insider transactions. The filing does not include any indication of a trading plan date or 10b5-1 instruction; that absence is explicitly observable in the form fields presented. From a governance perspective, the form meets Rule 144 content requirements but provides no additional context about the seller's rationale or any pre-existing trading plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	4800019.30	28093026	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2024	Stock Option Exercise	Issuer			10000	08/05/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Susan Burwig 5375 Medpace Way, Cincinnati OH 45227	Common	07/28/2025	7500	3376083.14

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MEDP Form 144 disclose about the planned sale?

The filing discloses an intended sale of 10,000 common shares via Fidelity on 09/03/2025 with an aggregate market value of $4,800,019.30.

How were the 10,000 shares acquired according to the filing?

The shares were acquired by a stock option exercise on 08/05/2024 and paid for in cash on that date.

Has the person sold any MEDP shares recently?

Yes. The filing reports a sale of 7,500 shares on 07/28/2025 for gross proceeds of $3,376,083.14.

How large is the planned sale relative to outstanding shares?

The filing lists 28,093,026 shares outstanding; the planned sale of 10,000 shares is a small fraction of that total.

Does the Form 144 state there is undisclosed material information?

No. By signing the notice the seller represents they do not know any material adverse information that is not publicly disclosed.